Literature DB >> 9605998

Serum cytokines in patients with Legionella pneumonia: relative predominance of Th1-type cytokines.

K Tateda1, T Matsumoto, Y Ishii, N Furuya, A Ohno, S Miyazaki, K Yamaguchi.   

Abstract

Serum samples from 14 patients with Legionella pneumonia were examined for the presence of cytokines. In spite of high levels of serum C-reactive protein in all patients during the acute phase in only four cases (one involving interleukin-1beta [IL-1beta], three involving IL-6, and none involving tumor necrosis factor alpha) was the concentration of cytokines more than 100 pg/ml. Th2 cytokines IL-4 and IL-10 were detected in only one patient each. In contrast, significant increases of serum gamma interferon (IFN-gamma) and IL-12 levels were observed during the acute phase in 6 and 11 cases, respectively. Interestingly, although serum IFN-gamma levels diminished thereafter, in seven cases IL-12 levels remained high or increased further during the convalescent phase. In an additional 22 cases clinically suspected to be but not diagnosed as Legionella pneumonia, increases of serum IL-12 levels were observed in 16 cases, whereas the remaining 6 cases showed no detectable IL-12. Our results demonstrate the relative predominance of Th1 cytokine production in Legionella pneumonia. Although the role and significance of prolonged increases in IL-12 levels in Legionella disease are unknown, our results should prompt further investigation of the host immune response in terms of Th1 and Th2 balance in legionellosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605998      PMCID: PMC104531          DOI: 10.1128/CDLI.5.3.401-403.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  23 in total

1.  Recombinant murine interferon-gamma reversibly activates rat alveolar macrophages to kill Legionella pneumophila.

Authors:  S J Skerrett; T R Martin
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

2.  Detection of Legionella spp. in bronchoalveolar lavage fluids by DNA amplification.

Authors:  B Jaulhac; M Nowicki; N Bornstein; O Meunier; G Prevost; Y Piemont; J Fleurette; H Monteil
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

Review 3.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  Onset and duration of urinary antigen excretion in Legionnaires disease.

Authors:  R B Kohler; W C Winn; L J Wheat
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

5.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

6.  IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila.

Authors:  T W Nash; D M Libby; M A Horwitz
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

7.  DNA sequence of mip, a Legionella pneumophila gene associated with macrophage infectivity.

Authors:  N C Engleberg; C Carter; D R Weber; N P Cianciotto; B I Eisenstein
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

8.  Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.

Authors:  C A Hunter; C S Subauste; V H Van Cleave; J S Remington
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

9.  Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection.

Authors:  C A Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

Review 10.  Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature.

Authors:  B D Kirby; K M Snyder; R D Meyer; S M Finegold
Journal:  Medicine (Baltimore)       Date:  1980-05       Impact factor: 1.889

View more
  20 in total

1.  Roles of interleukin-17 in an experimental Legionella pneumophila pneumonia model.

Authors:  Yoshifumi Kimizuka; Soichiro Kimura; Tomoo Saga; Makoto Ishii; Naoki Hasegawa; Tomoko Betsuyaku; Yoichiro Iwakura; Kazuhiro Tateda; Keizo Yamaguchi
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

Review 2.  Molecular pathogenesis of infections caused by Legionella pneumophila.

Authors:  Hayley J Newton; Desmond K Y Ang; Ian R van Driel; Elizabeth L Hartland
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 3.  Roles of liver innate immune cells in nonalcoholic fatty liver disease.

Authors:  Yu-Tao Zhan; Wei An
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

4.  Transient transgenic expression of gamma interferon promotes Legionella pneumophila clearance in immunocompetent hosts.

Authors:  J C Deng; K Tateda; X Zeng; T J Standiford
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Levels of gamma interferon and interleukin-4 are inversely related to the levels of their corresponding autoantibodies in patients with lower respiratory tract infection.

Authors:  R ElKarim; C Granert; L Lindquist; H Link; M Bakhiet
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Legionella pneumophila evades gamma interferon-mediated growth suppression through interleukin-10 induction in bone marrow-derived macrophages.

Authors:  Sadako Yoshizawa; Kazuhiro Tateda; Tetsuya Matsumoto; Fumio Gondaira; Shuichi Miyazaki; Theodore J Standiford; Keizo Yamaguchi
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

7.  Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila.

Authors:  Urvashi Bhan; Glenda Trujillo; Kenneth Lyn-Kew; Michael W Newstead; Xianying Zeng; Cory M Hogaboam; Arthur M Krieg; Theodore J Standiford
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

8.  In vivo effect of adhesion inhibitor heparin on Legionella pneumophila pathogenesis in a murine pneumonia model.

Authors:  Florence Ader; Rozenn Le Berre; Rémi Fackeure; Dominique Raze; Franco Dante Menozzi; Nathalie Viget; Karine Faure; Eric Kipnis; Benoît Guery; Sophie Jarraud; Jerome Etienne; Christian Chidiac
Journal:  Intensive Care Med       Date:  2008-03-26       Impact factor: 17.440

9.  Reduced interferon-gamma release in patients recovered from Legionnaires' disease.

Authors:  K D Lettinga; S Weijer; P Speelman; J M Prins; T Van Der Poll; A Verbon
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

10.  Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia.

Authors:  David K R Karaolis; Michael W Newstead; Xianying Zeng; Mamoru Hyodo; Yoshihiro Hayakawa; Urvhashi Bhan; Hallie Liang; Theodore J Standiford
Journal:  Infect Immun       Date:  2007-07-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.